Skip to content

Celcuity CELC Enterprise value

Enterprise value at other companies

Eli Lilly logo
Eli LillyLLY
$859.77B+10.6%
Gilead Sciences logo
Gilead SciencesGILD
$187.53B+19.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$16.77B+178%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.61B+304%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.02B+951%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.86B+2,204%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's enterprise value?
Celcuity (CELC) reported enterprise value of $5.51B in Q1 2026.
How has Celcuity's enterprise value changed year-over-year?
Celcuity's enterprise value increased by 1086.4% year-over-year, from $464.43M to $5.51B.
What is the long-term trend for Celcuity's enterprise value?
Over 5 years (2020 to 2025), Celcuity's enterprise value has grown at a 103.3% compound annual growth rate (CAGR), from $125.59M to $4.37B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.